End Users' Views and Preferences on Prescribing and Taking Postexposure Prophylaxis for Prevention of HIV: Methods to Support World Health Organization Guideline Development.
Identifieur interne : 000628 ( PubMed/Curation ); précédent : 000627; suivant : 000629End Users' Views and Preferences on Prescribing and Taking Postexposure Prophylaxis for Prevention of HIV: Methods to Support World Health Organization Guideline Development.
Auteurs : Rachel L. Beanland [Suisse] ; Cadi M. Irvine [Suisse] ; Kimberly Green [Ghana]Source :
- Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [ 1537-6591 ] ; 2015.
Descripteurs français
- KwdFr :
- Agents antiVIH (usage thérapeutique), Besoins et demandes de services de santé, Enquêtes et questionnaires, Guides de bonnes pratiques cliniques comme sujet, Humains, Infections à VIH (), Infections à VIH (transmission), Organisation mondiale de la santé, Prophylaxie après exposition, Préférence du patient.
- MESH :
English descriptors
- KwdEn :
- MESH :
- chemical , therapeutic use : Anti-HIV Agents.
- prevention & control : HIV Infections.
- transmission : HIV Infections.
- Health Services Needs and Demand, Humans, Patient Preference, Post-Exposure Prophylaxis, Practice Guidelines as Topic, Surveys and Questionnaires, World Health Organization.
Abstract
The 2014 World Health Organization guidelines for human immunodeficiency virus postexposure prophylaxis (PEP) are the first to combine recommendations for all populations and exposures. To inform the development of these guidelines, we gathered views of end users on key aspects of PEP provision. A mixed-methods approach was used to gather views from the populations for whom the guideline will be of relevance. Data gathered from an online survey, focus group discussions, and previously collected data from in-depth interviews with key populations were used to inform the development of recommendations, in particular where there is a paucity of evidence to assess the benefits and harms of an intervention. This was a successful method to gather end users' views and preferences; however, limitations exist in the generalizability and reliability of the evidence. Future guideline development processes should consider methods to include the views of end users to guide the decision-making process.
DOI: 10.1093/cid/civ070
PubMed: 25972503
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000628
Links to Exploration step
pubmed:25972503Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">End Users' Views and Preferences on Prescribing and Taking Postexposure Prophylaxis for Prevention of HIV: Methods to Support World Health Organization Guideline Development.</title><author><name sortKey="Beanland, Rachel L" sort="Beanland, Rachel L" uniqKey="Beanland R" first="Rachel L" last="Beanland">Rachel L. Beanland</name><affiliation wicri:level="1"><nlm:affiliation>Department of HIV/AIDS, World Health Organization, Geneva, Switzerland.</nlm:affiliation><country xml:lang="fr">Suisse</country><wicri:regionArea>Department of HIV/AIDS, World Health Organization, Geneva</wicri:regionArea></affiliation></author><author><name sortKey="Irvine, Cadi M" sort="Irvine, Cadi M" uniqKey="Irvine C" first="Cadi M" last="Irvine">Cadi M. Irvine</name><affiliation wicri:level="1"><nlm:affiliation>Department of HIV/AIDS, World Health Organization, Geneva, Switzerland.</nlm:affiliation><country xml:lang="fr">Suisse</country><wicri:regionArea>Department of HIV/AIDS, World Health Organization, Geneva</wicri:regionArea></affiliation></author><author><name sortKey="Green, Kimberly" sort="Green, Kimberly" uniqKey="Green K" first="Kimberly" last="Green">Kimberly Green</name><affiliation wicri:level="1"><nlm:affiliation>FHI 360, Accra, Ghana.</nlm:affiliation><country xml:lang="fr">Ghana</country><wicri:regionArea>FHI 360, Accra</wicri:regionArea></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2015">2015</date><idno type="RBID">pubmed:25972503</idno><idno type="pmid">25972503</idno><idno type="doi">10.1093/cid/civ070</idno><idno type="wicri:Area/PubMed/Corpus">000628</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000628</idno><idno type="wicri:Area/PubMed/Curation">000628</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000628</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">End Users' Views and Preferences on Prescribing and Taking Postexposure Prophylaxis for Prevention of HIV: Methods to Support World Health Organization Guideline Development.</title><author><name sortKey="Beanland, Rachel L" sort="Beanland, Rachel L" uniqKey="Beanland R" first="Rachel L" last="Beanland">Rachel L. Beanland</name><affiliation wicri:level="1"><nlm:affiliation>Department of HIV/AIDS, World Health Organization, Geneva, Switzerland.</nlm:affiliation><country xml:lang="fr">Suisse</country><wicri:regionArea>Department of HIV/AIDS, World Health Organization, Geneva</wicri:regionArea></affiliation></author><author><name sortKey="Irvine, Cadi M" sort="Irvine, Cadi M" uniqKey="Irvine C" first="Cadi M" last="Irvine">Cadi M. Irvine</name><affiliation wicri:level="1"><nlm:affiliation>Department of HIV/AIDS, World Health Organization, Geneva, Switzerland.</nlm:affiliation><country xml:lang="fr">Suisse</country><wicri:regionArea>Department of HIV/AIDS, World Health Organization, Geneva</wicri:regionArea></affiliation></author><author><name sortKey="Green, Kimberly" sort="Green, Kimberly" uniqKey="Green K" first="Kimberly" last="Green">Kimberly Green</name><affiliation wicri:level="1"><nlm:affiliation>FHI 360, Accra, Ghana.</nlm:affiliation><country xml:lang="fr">Ghana</country><wicri:regionArea>FHI 360, Accra</wicri:regionArea></affiliation></author></analytic><series><title level="j">Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</title><idno type="eISSN">1537-6591</idno><imprint><date when="2015" type="published">2015</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Anti-HIV Agents (therapeutic use)</term><term>HIV Infections (prevention & control)</term><term>HIV Infections (transmission)</term><term>Health Services Needs and Demand</term><term>Humans</term><term>Patient Preference</term><term>Post-Exposure Prophylaxis</term><term>Practice Guidelines as Topic</term><term>Surveys and Questionnaires</term><term>World Health Organization</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Agents antiVIH (usage thérapeutique)</term><term>Besoins et demandes de services de santé</term><term>Enquêtes et questionnaires</term><term>Guides de bonnes pratiques cliniques comme sujet</term><term>Humains</term><term>Infections à VIH ()</term><term>Infections à VIH (transmission)</term><term>Organisation mondiale de la santé</term><term>Prophylaxie après exposition</term><term>Préférence du patient</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Anti-HIV Agents</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>HIV Infections</term></keywords><keywords scheme="MESH" qualifier="transmission" xml:lang="en"><term>HIV Infections</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Agents antiVIH</term><term>Infections à VIH</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Health Services Needs and Demand</term><term>Humans</term><term>Patient Preference</term><term>Post-Exposure Prophylaxis</term><term>Practice Guidelines as Topic</term><term>Surveys and Questionnaires</term><term>World Health Organization</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Besoins et demandes de services de santé</term><term>Enquêtes et questionnaires</term><term>Guides de bonnes pratiques cliniques comme sujet</term><term>Humains</term><term>Infections à VIH</term><term>Organisation mondiale de la santé</term><term>Prophylaxie après exposition</term><term>Préférence du patient</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The 2014 World Health Organization guidelines for human immunodeficiency virus postexposure prophylaxis (PEP) are the first to combine recommendations for all populations and exposures. To inform the development of these guidelines, we gathered views of end users on key aspects of PEP provision. A mixed-methods approach was used to gather views from the populations for whom the guideline will be of relevance. Data gathered from an online survey, focus group discussions, and previously collected data from in-depth interviews with key populations were used to inform the development of recommendations, in particular where there is a paucity of evidence to assess the benefits and harms of an intervention. This was a successful method to gather end users' views and preferences; however, limitations exist in the generalizability and reliability of the evidence. Future guideline development processes should consider methods to include the views of end users to guide the decision-making process.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25972503</PMID><DateCreated><Year>2015</Year><Month>05</Month><Day>14</Day></DateCreated><DateCompleted><Year>2016</Year><Month>02</Month><Day>04</Day></DateCompleted><DateRevised><Year>2017</Year><Month>09</Month><Day>02</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1537-6591</ISSN><JournalIssue CitedMedium="Internet"><Volume>60 Suppl 3</Volume><PubDate><Year>2015</Year><Month>Jun</Month><Day>01</Day></PubDate></JournalIssue><Title>Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</Title><ISOAbbreviation>Clin. Infect. Dis.</ISOAbbreviation></Journal><ArticleTitle>End Users' Views and Preferences on Prescribing and Taking Postexposure Prophylaxis for Prevention of HIV: Methods to Support World Health Organization Guideline Development.</ArticleTitle><Pagination><MedlinePgn>S191-5</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/cid/civ070</ELocationID><Abstract><AbstractText>The 2014 World Health Organization guidelines for human immunodeficiency virus postexposure prophylaxis (PEP) are the first to combine recommendations for all populations and exposures. To inform the development of these guidelines, we gathered views of end users on key aspects of PEP provision. A mixed-methods approach was used to gather views from the populations for whom the guideline will be of relevance. Data gathered from an online survey, focus group discussions, and previously collected data from in-depth interviews with key populations were used to inform the development of recommendations, in particular where there is a paucity of evidence to assess the benefits and harms of an intervention. This was a successful method to gather end users' views and preferences; however, limitations exist in the generalizability and reliability of the evidence. Future guideline development processes should consider methods to include the views of end users to guide the decision-making process.</AbstractText><CopyrightInformation>© The Author 2015. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Beanland</LastName><ForeName>Rachel L</ForeName><Initials>RL</Initials><AffiliationInfo><Affiliation>Department of HIV/AIDS, World Health Organization, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Irvine</LastName><ForeName>Cadi M</ForeName><Initials>CM</Initials><AffiliationInfo><Affiliation>Department of HIV/AIDS, World Health Organization, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Green</LastName><ForeName>Kimberly</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>FHI 360, Accra, Ghana.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>WHO_001</GrantID><Agency>World Health Organization</Agency><Country>International</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Clin Infect Dis</MedlineTA><NlmUniqueID>9203213</NlmUniqueID><ISSNLinking>1058-4838</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D019380">Anti-HIV Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D019380" MajorTopicYN="N">Anti-HIV Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015658" MajorTopicYN="N">HIV Infections</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName><QualifierName UI="Q000635" MajorTopicYN="N">transmission</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006301" MajorTopicYN="N">Health Services Needs and Demand</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057240" MajorTopicYN="Y">Patient Preference</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D056990" MajorTopicYN="Y">Post-Exposure Prophylaxis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017410" MajorTopicYN="Y">Practice Guidelines as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014944" MajorTopicYN="N">World Health Organization</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">HIV</Keyword><Keyword MajorTopicYN="N">postexposure prophylaxis</Keyword><Keyword MajorTopicYN="N">preferences</Keyword><Keyword MajorTopicYN="N">qualitative</Keyword><Keyword MajorTopicYN="N">views</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>5</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>5</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>2</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25972503</ArticleId><ArticleId IdType="pii">civ070</ArticleId><ArticleId IdType="doi">10.1093/cid/civ070</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/SidaGhanaV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000628 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 000628 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= SidaGhanaV1
|flux= PubMed
|étape= Curation
|type= RBID
|clé= pubmed:25972503
|texte= End Users' Views and Preferences on Prescribing and Taking Postexposure Prophylaxis for Prevention of HIV: Methods to Support World Health Organization Guideline Development.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:25972503" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \
| NlmPubMed2Wicri -a SidaGhanaV1
| This area was generated with Dilib version V0.6.31. |  |